BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2018
View Archived Issues
Total surveillance leads to cell division atlas
Read More
Mutations in IRF2BPL causes neurodegeneration in humans and flies
Read More
ASD diagnosis branches out
Read More
Cancer immunotherapy could get metabolic leg up
Read More
FDA approves Ajovy for preventive treatment of migraine
Read More
AstraZeneca adopts Horizon Discovery's Edit-R crRNA libraries for genomics discovery platform
Read More
Efgartigimod phase II data in ITP support progression to phase III development
Read More
Azitra, The Jackson Laboratory awarded grant to identify compounds for treatment of skin infections
Read More
Glenmark to use Mitra's CANscript platform in support of immuno-oncology pipeline
Read More
CymaBay opens enrollment in phase III study of seladelpar for primary biliary cholangitis
Read More
Palobiofarma enrolling patients in phase I study of PBF-1129 for NSCLC
Read More
Gilead Sciences and Precision BioSciences collaborate to develop therapies against HBV
Read More
MaxCyte studies MCY-M11 in phase I for advanced ovarian cancer and peritoneal mesothelioma
Read More
Zhejiang Beta Pharma patents fibroblast growth factor receptor inhibitors
Read More
AbbVie presents novel optimized GABA-B PAMs with efficacy in animal models of seizure
Read More
DGMIF presents DN-200434 for ATC radioiodine therapy improvement
Read More
Strategic alliance between Bayer and Evotec results in the discovery of BAY-2395840
Read More
Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models
Read More
First phase I data presented for inhaled pirfenidone
Read More
Bristol-Myers Squibb initiates two phase III trials of BMS-986165 in plaque psoriasis
Read More
Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease
Read More
Phase II data presented for CFTR potentiator QBW-251
Read More